Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on September 16, 2016. The filing addresses a corporate governance event involving the departure of a director from the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the resignation of Dr. Emad Rizk from the Board of Directors, effective immediately on September 16, 2016. This departure was necessitated by his appointment as Chief Executive Officer and board director of Verscend Technologies, Inc., requiring his full-time attention. Consequently, the Board approved a reduction in the total number of directors from 8 to 7. The Company explicitly stated that the resignation was not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks, contingencies, or unusual items were disclosed in this report beyond the standard disclosure of the director's departure.
Key Facts for Investor Verification
- Dr. Emad Rizk resigned from the Accuray Board effective September 16, 2016.
- The resignation was due to a new full-time role at Verscend Technologies, Inc.
- The Board size was reduced from 8 to 7 directors following the resignation.
- The Company confirmed no disagreement existed between Dr. Rizk and the Company.
- No financial data or operational metrics are included in this specific filing.